Viatris | VTRS - Eigenkapital Und Reserven

Aktienkurs
13.20
Täglich Wechseln
-0.30 -2.22%
Monatlich
-17.24%
Jährlich
44.26%
Q1 Prognose
13.10




Eigenkapital Und Reserven Veränderung Datum
Celltrion KRW 16.7T 182.36B 2025-09
Cspc Pharmaceutical CNY 33.25B 984.93M 2025-06
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Divis Laboratories Ltd INR 154.13B 4.44B 2025-09
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Organigram Holdings CAD 369.46M 20.33M 2025-12
Ovoca Bio EUR 8.67M 4.76M 2022-06
Pharma Mar EUR 251.83M 54.32M 2025-12
Qiagen NV USD 3.78B 128.73M 2025-12
Sartorius EUR 2.67B 9.9M 2025-09
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Tilray USD 1.58B 39.08M 2025-09
Viatris USD 15.22B 352.9M 2025-09
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 14.47B 173.2M 2025-09